Publications
Publications
Show Results For
- All HBS Web
(560)
- Faculty Publications (154)
Page 1 of 154
Results →
- September 2024
- Case
Barbie: Reviving a Cultural Icon at Mattel (Abridged)
The 2023 release of live-action film Barbie, and its accompanying marketing blitz, incited a worldwide Barbie craze. Suddenly Barbie was everywhere, a celebrated icon reinstated at the forefront of cultural conversation. This goodwill stood in contrast to decades of... View Details
- August 2024
- Case
Barbie: Reviving a Cultural Icon at Mattel
The 2023 release of live-action film Barbie, and its accompanying marketing blitz, incited a worldwide Barbie craze. Suddenly Barbie was everywhere, a celebrated icon reinstated at the forefront of cultural conversation. This goodwill stood in contrast to decades of... View Details
- July 1, 2024
- Article
Research: Speed Matters When Companies Respond to Social Issues
By: Alison Wood Brooks, Jimin Nam, Maya Balakrishnan and Julian De Freitas
Companies and their leaders face new pressures to make public statements about controversial and sometimes divisive social and political issues. New research shows that timing matters: consumers perceive a relationship between speed and authenticity, and discount... View Details
- May 2024
- Teaching Note
AI Wars
By: Andy Wu and Matt Higgins
Teaching Note for HBS Case No. 723-434. In 2024, the world was looking to Google to see what the search giant and long-time putative technical leader in artificial intelligence (AI) would do to compete in the massively hyped technology of generative AI popularized over... View Details
- March–April 2024
- Article
How Companies Should Weigh in on a Controversy: A Better Approach to Stakeholder Management
By: David M. Bersoff, Sandra J. Sucher and Peter Tufano
Executives need guidance about managing their organizations’ engagement with societal issues—including hot-button topics such as gender, climate, and racial discrimination. Success in this realm does not mean avoiding public controversy or achieving unanimous support... View Details
- 2024
- Case
Christiana Figueres and the Paris Climate Negotiations (A)
By: James K. Sebenius, Laurence A. Green, Hannah Riley-Bowles, Lara SanPietro and Mina Subramanian
This three-part, stop action case study, structured for classroom discussion, centers on Harvard’s Program on Negotiation 2022 Great Negotiator, Christiana Figueres, and her efforts as Executive Secretary of the United Nations Framework Convention on Climate Change... View Details
- 2024
- Case
Christiana Figueres and the Paris Climate Negotiations (B)
By: James K. Sebenius, Laurence A. Green, Hannah Riley-Bowles, Lara SanPietro and Mina Subramanian
This three-part, stop action case study, structured for classroom discussion, centers on Harvard’s Program on Negotiation 2022 Great Negotiator, Christiana Figueres, and her efforts as Executive Secretary of the United Nations Framework Convention on Climate Change... View Details
- 2024
- Case
Christiana Figueres and the Paris Climate Negotiations: Figueres the Negotiator (C)
By: James K. Sebenius, Laurence A. Green, Hannah Riley-Bowles, Lara SanPietro and Mina Subramanian
This three-part, stop action case study, structured for classroom discussion, centers on Harvard’s Program on Negotiation 2022 Great Negotiator, Christiana Figueres, and her efforts as Executive Secretary of the United Nations Framework Convention on Climate Change... View Details
- 2023
- Working Paper
Corporate Leaders Say They Are for Stakeholder Capitalism—But Which Version Exactly?: A Critical Look at Four Varieties
By: Lynn S. Paine
The past few years have seen an outpouring of articles and statements heralding the
arrival of a new and more inclusive form of capitalism often called stakeholder capitalism. The
new capitalism promises to strengthen companies, improve outcomes for their... View Details
- June 2023 (Revised July 2024)
- Case
Biogen and the Aduhelm Melee
By: Amitabh Chandra and Lauren Gunasti
Alzheimer's Disease is a devastating condition affecting millions of Americans. At this time, there is no cure. In 2021, Biogen's Aduhelm (aducanumab) received FDA approval under the accelerated approval pathway after a controversial approval process.
This... View Details
This... View Details
- April 2023 (Revised February 2024)
- Case
AI Wars
By: Andy Wu, Matt Higgins, Miaomiao Zhang and Hang Jiang
In February 2024, the world was looking to Google to see what the search giant and long-time putative technical leader in artificial intelligence (AI) would do to compete in the massively hyped technology of generative AI. Over a year ago, OpenAI released ChatGPT, a... View Details
- February 2022 (Revised February 2023)
- Case
TikTok in 2020: Super App or Supernova? (Abridged)
By: Jeffrey F. Rayport, Dan Maher and Dan O'Brien
TikTok’s parent company, ByteDance, was launched in 2012 around a simple idea—helping users entertain themselves on their smartphones while on the Beijing Subway. In less than a decade, it had become one of the world’s most valuable private companies, with investors... View Details
- 2021
- Working Paper
Caccia Selvaggia: Myth, Rites, and the Right in Carlo Ginzburg's Storia notturna
By: Robert Fredona and Sophus A. Reinert
Carlo Ginzburg (b. 1939) is widely considered one of Europe’s leading historians. His masterpiece Storia notturna (Turin: Einaudi, 1989), widely praised for its extraordinary erudition and creativity, is now over three decades old but it continues to inspire... View Details
- October 2021 (Revised October 2022)
- Case
The Opioid Settlement and Controversy Over CEO Pay at AmerisourceBergen
By: Suraj Srinivasan and Li-Kuan Ni
In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices that critics alleged had contributed to the nationwide... View Details
Keywords: Opioids; Drug; Investors; Shareholder Activism; Investment Activism; Executive Compensation; Corporate Accountability; Corporate Governance; Governance Compliance; Governance Controls; Risk Management; Corporate Social Responsibility and Impact; Business and Shareholder Relations; Business and Stakeholder Relations; Legal Liability; Distribution Industry; Health Industry; Pharmaceutical Industry; United States; West Virginia; Tennessee; Ohio; Pennsylvania
- July 2021
- Teaching Note
Digital Transformation 2.0: CEO Elie Girard at Atos
By: Tsedal Neeley
Teaching Note for HBS Case No. 421-024. Elie Girard has taken the helm as CEO of multinational IT giant Atos to lead the company into the next era of digital transformation. Noticing that customers’ digital needs were evolving to become even more specialized and global... View Details
- 2024
- Working Paper
Fecal Microbiota Transplants —Too Simple to be Safe? Case Histories of Transformational Advances
By: Amar Bhide and Srikant M. Datar
By 2013, after many decades of very slow development and adoption, Fecal Microbiota Transplantation procedures were attracting widespread attention. This case history chronicles the: 1) pioneering fecal transplants performed in the 20th century; 2) development of the... View Details
- April 2021
- Background Note
HEAD vs. LEAD: Disruptions Originating at the High- vs. Low-End of the Market
By: Elie Ofek, Olivier Toubia and Didier Toubia
Twenty five years after it was initially proposed, Clay Christensen’s theory of disruptive innovation continues to be a major reference for entrepreneurs, corporate innovators, and investors. However, the term “disruptive innovation” is often used in ways and contexts... View Details
- April 2021
- Case
The Clean Network and the Future of Global Technology Competition
By: Meg Rithmire and Courtney Han
In May 2019, amidst of an ever-worsening trade war between the U.S. and China, President Donald Trump added Chinese telecom giant Huawei to the Department of Commerce’s “entity list,” essentially forbidding American firms from doing business with the company. Huawei,... View Details
- March 2021
- Supplement
Facebook's Libra (B): The Privatization of Money?
By: Marco Di Maggio, Ethan Rouen, George Serafeim and Amy Klopfenstein
This case addresses the events that took place following the conclusion of the case “Facebook’s Libra (A): The Privatization of Money?” In October 2019, several months after the conclusion of the A case, multiple members of the Libra Association announced that they... View Details
Keywords: Blockchain; Cryptocurrency; Accounting; Economics; Money; Governance; Governing and Advisory Boards; Policy; Governance Controls; Innovation and Invention; Innovation Strategy; Technological Innovation; Disruptive Innovation; Information Technology; Digital Platforms; Information Infrastructure; Technology Industry; Europe; Switzerland; United States; California
- March 2021 (Revised January 2023)
- Case
The Trouble with TCE
By: Vincent Pons, Rafael Di Tella and Galit Goldstein
Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other... View Details